KBY Biotech Indexv0.0.34
Search
← Pipeline|ADA-2164

ADA-2164

Approved
By Adamed
Source: Trial-derived·Trials: 4
Modality
Vaccine
MOA
EGFRi
Target
FcRn
Pathway
STING
Bladder CaCrohn's
Development Pipeline
Preclinical
~Oct 2009
→ ~Jan 2011
Phase 1
~Apr 2011
→ ~Jul 2012
Phase 2
~Oct 2012
→ ~Jan 2014
Phase 3
~Apr 2014
→ ~Jul 2015
NDA/BLA
~Oct 2015
→ ~Jan 2017
Approved
Apr 2017
→ Jul 2031
ApprovedCurrent
NCT06055652
2,523 pts·Bladder Ca
2017-04→2027-12·Active
NCT08116969
723 pts·Bladder Ca
2025-03→2029-01·Not yet recruiting
NCT06136251
2,119 pts·Bladder Ca
2023-02→2031-07·Terminated
+1 more trial
5,887 total pts1 indication
CompletedCurrentUpcoming
Catalysts (3)
2027-12-251.7y awayPh3 Readout· Bladder Ca
2029-01-032.8y awayPh3 Readout· Bladder Ca
2031-07-075.3y awayPh3 Readout· Bladder Ca
Trial Timeline
2017Q2Q3Q42018Q2Q3Q42019Q2Q3Q42020Q2Q3Q42021Q2Q3Q42022Q2Q3Q42023Q2Q3Q42024Q2Q3Q42025Q2Q3Q42026Q2Q3Q42027Q2Q3Q42028Q2Q3Q42029Q2Q3Q42030Q2Q3Q42031Q2Q3Q4
Approved
Active
Approved
Not yet…
Approved
Termina…
Approved
Not yet…
Catalysts
Ph3 Readout
2027-12-25 · 1.7y away
Bladder Ca
Ph3 Readout
2029-01-03 · 2.8y away
Bladder Ca
Ph3 Readout
2031-07-07 · 5.3y away
Bladder Ca
ActiveTerminatedNot yet recruiting|StartCompletionToday
Trials (4)
NCTPhaseIndicationStatusNEP
NCT06055652ApprovedBladder CaActive25236MWD
NCT08116969ApprovedBladder CaNot yet recr...723ORR
NCT06136251ApprovedBladder CaTerminated2119VA
NCT03749374ApprovedBladder CaNot yet recr...522PASI75
Competitors (10)
DrugCompanyPhaseTargetMOA
NiranesiranJohnson & JohnsonPhase 2KIF18AEGFRi
JNJ-5094Johnson & JohnsonPhase 2/3GIP-REGFRi
CevizanubrutinibJohnson & JohnsonPreclinicalFcRnCD47i
GelinaritideAbbViePreclinicalFcRnCFTRmod
GSK-2051GSKPhase 1PSMAEGFRi
TalalemzoparlimabGilead SciencesPhase 1FcRnTNFi
GIL-8529Gilead SciencesPhase 1/2JAK1EGFRi
SovafutibatinibModernaApprovedFcRnSHP2i
ITC-879Intra-CellularApprovedFcRnTYK2i
JAZ-8729Jazz PharmaPhase 2/3FcRnCAR-T BCMA